Medical Therapy and Prognosis in Chronic Heart Failure
Open Access
- 1 February 1995
- journal article
- Published by Elsevier in Cardiology Clinics
- Vol. 13 (1) , 5-26
- https://doi.org/10.1016/s0733-8651(18)30058-4
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Inhibition of cytokine production by a new inotropic agent, vesnarinone, in human lymphocytes, T cell line, and monocytic cell lineLife Sciences, 1994
- Angiotensin II Receptor Blockade: An Innovative Approach to Cardiovascular PharmacotherapyThe Journal of Clinical Pharmacology, 1993
- Intractable heart failure despite angiotensin-converting enzyme inhibitors, digoxin, and diuretics: Long-term effectiveness of add-on therapy with pimobendanAmerican Heart Journal, 1991
- Flosequinan: A vasodilator with positive inotropic activityAmerican Heart Journal, 1991
- A Comparison of Oral Milrinone, Digoxin, and Their Combination in the Treatment of Patients with Chronic Heart FailureNew England Journal of Medicine, 1989
- Prevention and Reversal of Nitrate Tolerance in Patients with Congestive Heart FailureNew England Journal of Medicine, 1987
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986
- Comparative effects of captopril and isosorbide dinitrate on pulmonary arteriolar resistance and right ventricular function in patients with severe left ventricular failure: Results of a randomized crossover studyAmerican Heart Journal, 1985
- Evaluation of a New Bipyridine Inotropic Agent — Milrinone — in Patients with Severe Congestive Heart FailureNew England Journal of Medicine, 1983
- Heart Failure in OutpatientsNew England Journal of Medicine, 1982